相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Economic evaluation of irbesartan in combination with hydrochlorothiazide in the treatment of hypertension in Greece
Nikos Maniadakis et al.
EUROPEAN JOURNAL OF HEALTH ECONOMICS (2011)
Cost Effectiveness of Angiotensin Receptor Blocker Monotherapy in Patients with Hypertension in the Netherlands A Comparative Analysis Using Clinical Trial and Drug Utilization Data
Cornelis Boersma et al.
AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS (2010)
Impact of Two Medicaid Prior-Authorization Policies on Antihypertensive Use and Costs Among Michigan and Indiana Residents Dually Enrolled in Medicaid and Medicare: Results of a Longitudinal, Population-Based Study
Michael R. Law et al.
CLINICAL THERAPEUTICS (2010)
Economic impact of switching from valsartan to other angiotensin receptor blockers in patients with hypertension
J. Signorovitch et al.
CURRENT MEDICAL RESEARCH AND OPINION (2010)
Economic evaluation of four angiotensin II receptor blockers in the treatment of hypertension
Lesley-Ann Miller et al.
CURRENT MEDICAL RESEARCH AND OPINION (2010)
Prior Authorization for Antidepressants in Medicaid Effects Among Disabled Dual Enrollees
Alyce S. Adams et al.
ARCHIVES OF INTERNAL MEDICINE (2009)
Hypertension guidelines
Christopher E. Clark et al.
BRITISH JOURNAL OF GENERAL PRACTICE (2009)
Blood pressure reduction, persistence and costs in the evaluation of antihypertensive drug treatment - a review
Peter Bramlage et al.
CARDIOVASCULAR DIABETOLOGY (2009)
Valsartan Improves Endothelial Dysfunction in Hypertension: A Randomized, Double-Blind Study
Nikolaos Tzemos et al.
CARDIOVASCULAR THERAPEUTICS (2009)
Nebivolol: A Third-Generation beta-Blocker for Hypertension
Judy W. M. Cheng
CLINICAL THERAPEUTICS (2009)
The value of irbesartan in the management of hypertension
Peter Bramlage et al.
EXPERT OPINION ON PHARMACOTHERAPY (2009)
Valsartan vs. other angiotensin II receptor blockers in the treatment of hypertension: a meta-analytical approach
R. M. Nixon et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2009)
2007 ESH/ESC Guidelines for the management of hypertension, from theory to practice: global cardiovascular risk concept
Massimo Volpe et al.
JOURNAL OF HYPERTENSION (2009)
Official recommendations and guidelines for the management and reimbursement of severe hypertension as a chronic disease
Jean-Marc Boivin et al.
PRESSE MEDICALE (2009)
Angiotensin-receptor blockers as therapy for mild-to-moderate hypertension-associated non-alcoholic steatohepatitis
Eugen Florin Georgescu et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2009)
Long-term effects of angiotensin II receptor blockade with valsartan on carotid arterial stiffness and hemodynamic alterations in patients with essential hypertension
Takafumi Okura et al.
CLINICAL AND EXPERIMENTAL HYPERTENSION (2008)
Economic benefits of treating high-risk hypertension with angiotensin II receptor antagonists (blockers)
Antonio Coca
CLINICAL DRUG INVESTIGATION (2008)
New guidelines of the European Society of Hypertension
Julian Segura et al.
CURRENT HYPERTENSION REPORTS (2008)
Switch strategies in the management of hypertension: a cost minimisation analysis of angiotensin receptor blocker based regimen
J. D. Belsey
CURRENT MEDICAL RESEARCH AND OPINION (2008)
Cost-Effectiveness Analysis: Controlled-Release Nifedipine and Valsartan Combination Therapy in Patients with Essential Hypertension: The Adalat CR and Valsartan Cost-Effectiveness Combination (ADVANCE-Combi) Study
Ikuo Saito et al.
HYPERTENSION RESEARCH (2008)
Evaluation of the clinical outcomes of switching patients from atorvastatin to simvastatin and losartan to candesartan in a primary care setting: 2 years on
J. Usher-Smith et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2008)
Cost-effectiveness of irbesartan/hydrochlorothiazide in patients with hypertension: an economic evaluation for Sweden
M. Ekman et al.
JOURNAL OF HUMAN HYPERTENSION (2008)
A randomized, double-blind study of valsartan versus metoprolol on arterial distensibility and endothelial function in essential hypertension
Markus Kosch et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2008)
World Health Organization (WHO) and International Society of Hypertension (ISH) risk prediction charts: assessment of cardiovascular risk for prevention and control of cardiovascular disease in low and middle-income countries
Shanthi Mendis et al.
JOURNAL OF HYPERTENSION (2007)
Angiotensin receptor blockers on the formularies of Medicare drug plans
Walid F. Gellad et al.
JOURNAL OF GENERAL INTERNAL MEDICINE (2007)
Investigation of the effect of a countywide protected learning time scheme on prescribing rates of ramipril: interrupted time series study
A. N. Siriwardena et al.
FAMILY PRACTICE (2007)
Controlled release nifedipine and valsartan combination therapy in patients with essential hypertension: The adalat CR and valsartan cost-effectiveness combination (ADVANCE-Combi) study
Ikuo Saito et al.
HYPERTENSION RESEARCH (2006)
Queen Mary Utilization of Antihypertensive Drugs Study: Side-effects of antihypertensive drugs
BMY Cheung et al.
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS (2005)
Effects of a prior-authorization policy for celecoxib on medical service and prescription drug use in a managed care medicaid population
DM Hartung et al.
CLINICAL THERAPEUTICS (2004)
Modern robust data analysis methods: Measures of central tendency
RR Wilcox et al.
PSYCHOLOGICAL METHODS (2003)
Comparative cost effectiveness of angiotensin II receptor blockers in a US managed care setting - Olmesartan medoxomil compared with losartan, valsartan, and irbesartan
WR Simons
PHARMACOECONOMICS (2003)
Angiotensin II antagonists in the treatment of hypertension - Effective and efficient?
J Muller-Nordhorn et al.
HERZ (2003)
A retrospective electronic chart review of blood pressure changes in elderly patients treated with amlodipine or an angiotensin-converting enzyme inhibitor or angiotensin II receptor blocker
A Dollar et al.
CLINICAL THERAPEUTICS (2002)
Isolating the cost of osteoporosis-related fracture for postmenopausal women - A population-based study
BC Martin et al.
GERONTOLOGY (2001)
分享论文
